News
Across hundreds of published papers, CBER’s new chief has argued for more stringent measures of assessing drugs for cancer ...
WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his ...
The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized COVID-19 restrictions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results